The Feinstein Institutes

New findings from the Feinstein Institutes 🧠 🔬 A new study led by Elvisha Dhamala, assistant professor in the Institute of Behavioral Sciences at the Feinstein Institutes, shows how sex and gender may influence the brain and, ultimately, a person’s health. The findings suggest that sex and gender are distinct from one another and should be considered separately in future scientific research. Read the study published in Science Advances: https://bit.ly/4d5w4vj #research #behavioralscience

Great news in bioelectronic medicine! SetPoint Medical announced significant positive results from its vagus nerve stimulation RESET-RA clinical trial treating moderate to severe rheumatoid arthritis. Decades of research from Kevin Tracey's lab and scientists at the Feinstein Institutes for Medical Research, and others worldwide, this is a major step toward making the first #VNS neuromodulation device available for patients.

It was an honor to host Brazilian Senator and disabilities activist Mara Gabrilli at the Institute of Bioelectronic Medicine last month. Senator Gabrilli visited Professor Chad Bouton's lab, where the research team shared groundbreaking results from our double neural bypass study and introduced her to a clinical trial participant working with the team. A life-changing accident in 1993 left Senator Gabrilli paralyzed. Since then, she’s become a dedicated advocate for those living with #paralysis. We deeply appreciate her support as we work towards developing new #bioelectronic therapies. Instituto Mara Gabrilli

New research findings 🔬 Blood biomarkers could be used to help identify the risk of psychotic symptoms in those who suffer from Alzheimer’s disease. Feinstein Institutes’ associate professors at the Institute of Molecular Medicine Jeremy L. Koppel, MD and Jesus J. Gomar, published new findings in the JAMA, Journal of the American Medical Association Psychiatry that suggests the presence of a certain tau protein could be used to identify the condition early. Explore how these findings may lead to new ways to diagnose and treat the disease for the millions living with #Alzheimer’s disease. https://bit.ly/3xvXHPb

Before you dive into the social media trends and try #vagusnerve stimulation activities suggested by influencers, consider the scientific evidence. In a recent New Scientist article written by Kevin Tracey, Feinstein Institutes for Medical Research President and CEO, he explains what vagus nerve stimulation is and the difference between humming or cold-water immersion and FDA-approved VNS devices used to treat diseases caused by inflammation. 🔗 Click this link below to read the full article.

Mark your calendars for the 6th BEM Summit on March 4-5, 2025. 📆 The Feinstein Institutes invites you to explore the latest in bioelectronic medicine research, #vagusnerve stimulation, and other technologies reshaping the way we treat disease during this special event. You'll have a chance to connect with the experts leading the research, share research during poster sessions and get inspired during insightful scientific sessions. Feinstein Institutes’ Stavros Zanos, Associate Professor of Institute of Bioelectronic Medicine will co-chair the event with Hubert Lim, a University of Minnesota Professor of Biomedical Engineering and Otolaryngology. Get your ticket and learn more here: https://bit.ly/4evIMF9 #bioelectronicmedicine #vagusnerve #research Earl E. Bakken Medical Devices Center, UMN Institute for Engineering in Medicine, University of Minnesota

That's a wrap! 🔬 It was a full day of scientific collaboration and celebration at the 11th annual Ross Prize Symposium. Congratulations to Michelle Monje, MD, PhD, who received this year's prize for her #groundbreaking research relating to the neuroscience of cancer and its implications for therapies. Every year, the Ross Prize honors those making translational breakthroughs in molecular medicine. If you think someone should be nominated for 2025, click the link for more information. https://bit.ly/3xuKw0O Northwell Health Foundation Stanford University The New York Academy of Sciences David H. Gutmann Shawn Hervey-Jumper

This week’s Curing with Sound podcast features Stavros Zanos, MD, PhD, associate professor at the Institute of Bioelectronic Medicine at The Feinstein Institutes. Dr. Zanos discusses the potential of focused ultrasound neuromodulation to treat a wide range of inflammatory and cardiovascular diseases, including promising study results for pulmonary arterial hypertension. 🎧Tune in and subscribe today: https://bit.ly/3XvVm1e

It’s important to highlight the dedicated work of researchers at the Feinstein Institutes and worldwide who are investigating #vagusnerve stimulation (VNS) to treat #depression and other mental health disorders. Kevin Tracey, President and CEO of the Feinstein Institutes, discusses the potential VNS has in reducing inflammation in the body to better treat mental health conditions. #VNS #mentalhealth Read more: https://bit.ly/3Xsarkd

We are just 8 days away from recognizing Michelle Monje, MD, PhD from Stanford University as this year’s Ross Prize in Molecular Medicine recipient. She will discuss her groundbreaking research relating to the neuroscience of cancer and its implications for novel therapies in her keynote presentation. Now in its 11th year, the Ross Prize is given to investigators whose research shows high potential for transforming how we treat and cure diseases. You’ll also get a chance to hear from other renowned scientists ⬇ David H. Gutmann, MD, PhD Shawn Hervey-Jumper, MD Mario Suva, MD, PhD There’s still time to join us on June 20 in person or virtually for the half-day symposium. Register here: https://lnkd.in/eXk65dzX The New York Academy of Sciences